PMCID: PMC4811838 DOI: 10.1007/s40121-016-0105-2
Concomitant antibiotic use during treatment for Clostridium difficile infection (CDI) increases the risk of recurrence. Across a network of children's hospitals, 46% of patients treated for CDI received concomitant antibiotics for a median of 7 days. Concomitant antibiotic use was more common among patients with malignancies, and solid organ or bone marrow transplant. Unnecessary concomitant antibiotic use in CDI patients is a potential target for pediatric antimicrobial stewardship.
Infect Dis Ther
Clostridium difficile infection; Concomitant antibiotics; Pediatric; Children; Babies; C-diff
Stevens VW, Thurm C, Schwab EM, et al. Use of Concomitant Antibiotics During Treatment for Clostridium difficile Infection (CDI) in Pediatric Inpatients: An Observational Cohort Study. Infect Dis Ther. 2016;5(1):45-51. doi:10.1007/s40121-016-0105-2